In vitro stimulation of the human colon cancer cell line HT29 identified SerpinA3 as a driver of cancer cell proliferation via AKT pathway activation, highlighting the protein SerpinA3, which is released from failing hearts, as a potential driver of colon cancer tumorigenesis. This evidence concerns the gene AKT1 and colonic neoplasm.